BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.42B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.87B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$704M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$517M |
| 5 |
Nike
NKE
|
+$489M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$301M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$283M |
| 3 |
State Street SPDR S&P Retail ETF
XRT
|
+$156M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$72M |
| 5 |
NVIDIA
NVDA
|
+$68.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.15% |
| 2 | Consumer Discretionary | 6.92% |
| 3 | Financials | 5.66% |
| 4 | Healthcare | 5.15% |
| 5 | Industrials | 3.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EDN
3651
Edenor
EDN
$1.04B
| $6.54K | ﹤0.01% |
+971
| New | +$5.82K |
|
|
ATNX
3652
DELISTED
Athenex, Inc. Common Stock
ATNX
| $6.54K | ﹤0.01% |
394
-769
| -66% | -$15K |
|
|
LITS
3653
Lite Strategy Inc
LITS
$30.4M
| $6.5K | ﹤0.01% |
540
-1,070
| -66% | -$42K |
|
|
SYRS
3654
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $6.43K | ﹤0.01% |
540
-735
| -58% | -$13.1K |
|
3655
Priority Technology Holdings
PRTH
$446M
| $6.41K | ﹤0.01% |
1,114
-1,250
| -53% | -$7.25K |
|
|
NTP
3656
DELISTED
Nam Tai Property Inc.
NTP
| $6.14K | ﹤0.01% |
+982
| New | +$8.09K |
|
3657
Santander
BSBR
$43.3B
| $6.12K | ﹤0.01% |
795
-42,776
| -98% | -$267K |
|
3658
Pulse Biosciences
PLSE
$3.19B
| $6.03K | ﹤0.01% |
1,241
-1,757
| -59% | -$14.4K |
|
|
CWBC
3659
Community West Bancshares
CWBC
$705M
| $6.02K | ﹤0.01% |
258
+200
| +345% | +$4.57K |
|
3660
iShares MSCI USA Momentum Factor ETF
MTUM
$26.3B
| $5.89K | ﹤0.01% |
35
-5,393
| -99% | -$888K |
|
3661
Value Line
VALU
$366M
| $5.83K | ﹤0.01% |
87
-131
| -60% | -$7.7K |
|
3662
Harrow
HROW
$1.44B
| $5.62K | ﹤0.01% |
824
+402
| +95% | +$3.1K |
|
3663
HSBC
HSBC
$358B
| $5.47K | ﹤0.01% |
160
-25,888
| -99% | -$893K |
|
3664
Arq
ARQ
$100M
| $5.23K | ﹤0.01% |
841
+787
| +1,457% | +$4.99K |
|
3665
Banco Santander Chile
BSAC
$16.1B
| $5.22K | ﹤0.01% |
231
-243
| -51% | -$4.86K |
|
3666
Farmers & Merchants Bancorp
FMAO
$487M
| $5.03K | ﹤0.01% |
139
-40
| -22% | -$1.33K |
|
3667
NACCO Industries
NC
$316M
| $5.02K | ﹤0.01% |
128
-3
| -2% | -$99 |
|
3668
RGC Resources
RGCO
$225M
| $4.91K | ﹤0.01% |
227
-1
| -0.4% | -$22 |
|
|
EPIX
3669
DELISTED
ESSA Pharma
EPIX
| $4.89K | ﹤0.01% |
792
+736
| +1,314% | +$6.47K |
|
3670
Hercules Capital
HTGC
$3.16B
| $4.83K | ﹤0.01% |
267
| – | – |
|
|
DRD
3671
DRDGold
DRD
$2.07B
| $4.79K | ﹤0.01% |
511
| – | – |
|
|
HOOK
3672
DELISTED
HOOKIPA Pharma
HOOK
| $4.66K | ﹤0.01% |
204
-249
| -55% | -$4.46K |
|
|
VNE
3673
DELISTED
Veoneer, Inc.
VNE
| $4.66K | ﹤0.01% |
126
-130
| -51% | -$4.63K |
|
3674
iShares International Treasury Bond ETF
IGOV
$1.54B
| $4.64K | ﹤0.01% |
100
| – | – |
|
|
AXDX
3675
DELISTED
Accelerate Diagnostics
AXDX
| $4.61K | ﹤0.01% |
320
-486
| -60% | -$13.8K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2022 Portfolio in Review
As of Q1 2022, BNP Paribas Financial Markets held 4,480 positions worth $74.4B, up 5.9% from $70.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $8.44B of net new capital in Q1 2022, opening 238 new positions and adding to 1,135 existing holdings. Its largest new stake was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $283M trimmed.
- BNP Paribas Financial Markets's largest Q1 2022 buy was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2022, an estimated $2.42B increase.
- BNP Paribas Financial Markets's biggest Q1 2022 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $283M.
- BNP Paribas Financial Markets fully exited Xilinx Inc in Q1 2022, selling an estimated $301M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $74.4B portfolio in Q1 2022.
- BNP Paribas Financial Markets opened 238 new positions and closed 335 in Q1 2022.
- BNP Paribas Financial Markets's portfolio value rose 5.9% quarter-over-quarter to $74.4B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.